Vineti

Vineti

Vineti

The first commercial, cloud-based software platform to expand patient access to life-saving cell and gene therapies
Type
B2b
Raised
$82.3M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$35,000,000
Venture capital (Series C) - 2020
Canaan Partners Casdin Capital Cardinal Health +6
$33,500,000
Venture capital (Series B) - 2018
GE Ventures Casdin Capital DFJ +4
Team Size
1–10
Employees
$35,000,000 Venture capital (Series C)
Pulse 2.0

Personalized Therapeutics Company Vineti Raises $35 Million

MedCity News

Vineti, Deloitte Consulting partner software systems to improve cell, gene therapy access

$33,500,000 Venture capital (Series B)
FinSMEs

Vineti Closes $33.5M in Series B Funding

Funding Health Cloud
$13,750,000 Venture capital (Series A)
PE HUB

Vineti nets $13.75 mln Series A

Data leaks